Literature DB >> 28949051

Distinct peripheral vs mucosal T-cell phenotypes in chlamydia-infected women.

Brian M O Ogendi1, Rakesh K Bakshi1, Steffanie Sabbaj1, LaDraka' Brown1, Jeannette Y Lee2, Richa Kapil1, William M Geisler1.   

Abstract

PROBLEM: Differences in circulating (peripheral) and mucosal T-cell phenotypes in chlamydia-infected women remain largely unknown. METHOD OF STUDY: Thirteen paired mononuclear cell specimens from blood and cervicovaginal lavages collected from chlamydia-infected women were stained and analyzed using ten-color cell surface flow cytometry for T-cell distribution, activation status, homing, and T helper (Th)-associated chemokine receptors (CKRs).
RESULTS: A higher proportion of genital mucosal T-cells were activated (CD38+ HLA-DR+ ) and expressed CCR5 and Th1-associated CKR CXCR3+ CCR5+ compared to peripheral T-cells, but a lower proportion of mucosal T-cells expressed homing CKR CCR7, Th-2 associated CKR CCR4, and CXCR3+ CCR4+ for both T-cell subsets.
CONCLUSION: T-cell phenotypes differed in the peripheral vs genital mucosa compartments in chlamydia-infected women. As chlamydia infects mucosal epithelial cells, the finding of a higher frequency of activated T-cells and Th-1 phenotypes in the mucosa likely reflects an adaptive immune response to infection.
© 2017 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990Chlamydiazzm321990; T-cell; mucosal; peripheral; phenotype; receptor

Mesh:

Year:  2017        PMID: 28949051      PMCID: PMC5681419          DOI: 10.1111/aji.12768

Source DB:  PubMed          Journal:  Am J Reprod Immunol        ISSN: 1046-7408            Impact factor:   3.886


  7 in total

1.  Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses.

Authors:  Shihong Zhang; Rakesh K Bakshi; Pothakamuri Venkata Suneetha; Paraskevi Fytili; Dinler A Antunes; Gustavo F Vieira; Roland Jacobs; Christoph S Klade; Michael P Manns; Anke R M Kraft; Heiner Wedemeyer; Verena Schlaphoff; Markus Cornberg
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P- and E-selectin on T lymphocytes of patients with juvenile idiopathic arthritis.

Authors:  Andrew C Issekutz; Patrick J Quinn; Bianca Lang; Suzanne Ramsey; Adam M Huber; Derek Rowter; Mohan Karkada; Thomas B Issekutz
Journal:  Arthritis Rheum       Date:  2011-11

3.  Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential.

Authors:  Alison Swaims-Kohlmeier; Richard E Haaland; Lisa B Haddad; Anandi N Sheth; Tammy Evans-Strickfaden; L Davis Lupo; Sarah Cordes; Alfredo J Aguirre; Kathryn A Lupoli; Cheng-Yen Chen; Igho Ofotukun; Clyde E Hart; Jacob E Kohlmeier
Journal:  J Immunol       Date:  2016-05-27       Impact factor: 5.422

4.  Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of regulatory T cells in the inflamed human liver.

Authors:  Ye H Oo; Chris J Weston; Patricia F Lalor; Stuart M Curbishley; David R Withers; Gary M Reynolds; Shishir Shetty; Jehan Harki; Jean C Shaw; Bertus Eksteen; Stefan G Hubscher; Lucy S K Walker; David H Adams
Journal:  J Immunol       Date:  2010-02-17       Impact factor: 5.422

5.  A distinct cellular profile is seen in the human endocervix during Chlamydia trachomatis infection.

Authors:  Mercedes Ficarra; Joyce S A Ibana; Constance Poretta; Liang Ma; Leann Myers; Stephanie N Taylor; Sheila Greene; Barbara Smith; Michael Hagensee; David H Martin; Alison J Quayle
Journal:  Am J Reprod Immunol       Date:  2008-11       Impact factor: 3.886

6.  CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa.

Authors:  A J Olive; D C Gondek; M N Starnbach
Journal:  Mucosal Immunol       Date:  2010-09-15       Impact factor: 7.313

7.  Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity.

Authors:  Rodolfo D Vicetti Miguel; Stephen A K Harvey; William A LaFramboise; Seth D Reighard; Dean B Matthews; Thomas L Cherpes
Journal:  PLoS One       Date:  2013-03-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.